HOME >> MEDICINE >> NEWS
Revised Bethesda guidelines effective at identifying patients at risk of colorectal cancer

The revised Bethesda guidelines, used for screening patients for a type of hereditary colorectal cancer, are effective for determining which patients should undergo further genetic testing, according to a study in the April 27 issue of JAMA.

Hereditary nonpolyposis colorectal cancer (HNPCC), also named Lynch syndrome, is a genetic disorder that accounts for approximately 1 percent to 3 percent of all colorectal cancers, according to background information in the article. HNPCC is caused by mutations in genes, mainly MSH2 and MLH1. In HNPCC, colorectal tumors have a DNA abnormality called microsatellite instability. Although a great advance in the understanding of the molecular basis of HNPCC has taken place in the last decade, optimal selection of individuals for HNPCC genetic testing remains challenging.

Virginia Pinol, M.D., of the University of Barcelona, Spain, and colleagues conducted a study to determine the most effective and efficient way to detect MSH2 or MLH1 gene carriers in patients with newly diagnosed colorectal cancers. The study included 1,222 patients from 20 hospitals in Spain with newly diagnosed colorectal cancer between November 1, 2000 and October 31, 2001. Patients underwent microsatellite instability testing and MSH2/MLH1 immunostaining (laboratory technique used to determine properties of tissue). Patients whose tumors exhibited microsatellite instability and/or lack of protein expression underwent MSH2/MLH1 germline (cells that have genetic material that may be passed to a child) testing.

Two hundred eighty-seven patients (23.5 percent) fulfilled the revised Bethesda guidelines. Ninety-one patients (7.4 percent) had a mismatch repair deficiency. The researchers found that strategies based on either microsatellite instability testing or immunostaining patients according to the revised Bethesda guidelines were the most effective (sensitivity, 81.8 percent and 81.8 percent; specificity, 98.0 percent and 98.2 perc
'"/>

Contact: Antoni Castells, M.D.
castells@clinic.ub.es
JAMA and Archives Journals
26-Apr-2005


Page: 1 2

Related medicine news :

1. Revised classification system is effective for predicting breast cancer outcome in some patients
2. ACC/AHA release revised UA/NSTEMI guidelines
3. Quality of treatment guidelines
4. Medical residents unclear about TB guidelines
5. Emergency department guidelines enhance quality patient care
6. International journal group updates guidelines on registration of clinical trials
7. Panel offers guidelines on skin reactions to new class of cancer drugs
8. New prostate cancer clinical guidelines to be released
9. Clinical guidelines for blood conservation during cardiac procedures developed
10. New reflux guidelines released
11. Lack of guidelines on kidney stone attacks could put travel workers and passengers at risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... ... Talented host, actor Rob Lowe, is introducing a segment ... of "Success Files," which is an award-winning educational program broadcasted on PBS Member ... with passion and integrity. , Sciatica occurs when the sciatic nerve in the ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & ... by Moonlight to raise money for the American Heart Association Heart Walk. Teams of ... will work together to keep their treadmills moving for 5 hours. Treadmills will start ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/22/2017)... -- As the latest Obamacare repeal effort moves is debated, ... and Lindsey Graham (R-SC) medical device market ... is in an odd place.  The industry wants repeal ... on medical device sales passed along with the Affordable ... visits and hospital customers with the funding to invest ...
Breaking Medicine Technology:
Cached News: